Maria Baccala

Learn More
We performed a retrospective audit of desmopressin (DDAVP) usage to assist in the functional characterisation of von Willebrand disease (VWD). Data was evaluated for 208 patients, comprising those with VWD (Type 1 [n=160], Type 2A [n=19], Type 2M [n=10]), plus 19 individuals with haemophilia or carriers of haemophilia. Laboratory testing comprised pre- and(More)
We performed a retrospective audit of cross-laboratory testing of desmopressin and factor concentrate therapy to assess the potential utility of supplementary testing using the PFA-100 with functional von Willebrand factor (VWF) activity testing. Data were evaluated for a large number of patients with von Willebrand disease of type 1, type 2A or type 2M, as(More)
We have combined the retrograde Fluoro-Gold (FG) and anterograde autoradiographic (AR) procedures to yield a sensitive high resolution technique by which afferent and efferent connections can be visualized from a single intracerebral injection site. Combined FG/AR sections show excellent results, with no apparent loss of signal compared to performing either(More)
  • 1